Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG10432)
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
ADAMTS18
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Browse Drug
Ferritin heavy chain (FTH1) [Suppressor; Marker]
In total 1 item(s) under this target | ||||
Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | |||
Target for Ferroptosis | Marker/Suppressor | |||
Responsed Disease | Hereditary Leiomyomatosis | ICD-11: 2C90 | ||
Responsed Drug | Curcumin | Investigative | ||
Pathway Response | Fatty acid metabolism | hsa01212 | ||
Ferroptosis | hsa04216 | |||
Cell Process | Cell ferroptosis | |||
Cell proliferation | ||||
In Vitro Model |
A-498 cells | Renal cell carcinoma | Homo sapiens | CVCL_1056 |
786-O cells | Renal cell carcinoma | Homo sapiens | CVCL_1051 | |
Response regulation | Curcumin induces ferroptosis in tumor cells by upregulating the expression of ADAMTS18, thereby enhancing the sensitivity of clear cell renal cell carcinoma (ccRCC) to sunitinib. And Curcumin can significantly inhibit FTH1 and FTL1 gene expression in tumor tissues of nude mice. | |||
Hereditary Leiomyomatosis [ICD-11: 2C90]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | |||
Target Regulator | A disintegrin and metalloproteinase with thrombospondin motifs 18 (ADAMTS18) | Protein coding | ||
Responsed Drug | Curcumin | Investigative | ||
Pathway Response | Fatty acid metabolism | hsa01212 | ||
Ferroptosis | hsa04216 | |||
Cell Process | Cell ferroptosis | |||
Cell proliferation | ||||
In Vitro Model |
A-498 cells | Renal cell carcinoma | Homo sapiens | CVCL_1056 |
786-O cells | Renal cell carcinoma | Homo sapiens | CVCL_1051 | |
Response regulation | Curcumin induces ferroptosis in tumor cells by upregulating the expression of ADAMTS18, thereby enhancing the sensitivity of clear cell renal cell carcinoma (ccRCC) to sunitinib. And Curcumin can significantly inhibit FTH1 and FTL1 gene expression in tumor tissues of nude mice. | |||
Curcumin
[Investigative]
In total 1 item(s) under this drug | ||||
Experiment 1 Reporting the Ferroptosis-centered Drug Response | [1] | |||
Drug for Ferroptosis | Inducer | |||
Response Target | Ferritin heavy chain (FTH1) | Suppressor; Marker | ||
Responsed Disease | Hereditary Leiomyomatosis | ICD-11: 2C90 | ||
Pathway Response | Fatty acid metabolism | hsa01212 | ||
Ferroptosis | hsa04216 | |||
Cell Process | Cell ferroptosis | |||
Cell proliferation | ||||
In Vitro Model |
A-498 cells | Renal cell carcinoma | Homo sapiens | CVCL_1056 |
786-O cells | Renal cell carcinoma | Homo sapiens | CVCL_1051 | |
Response regulation | Curcumin induces ferroptosis in tumor cells by upregulating the expression of ADAMTS18, thereby enhancing the sensitivity of clear cell renal cell carcinoma (ccRCC) to sunitinib. And Curcumin can significantly inhibit FTH1 and FTL1 gene expression in tumor tissues of nude mice. | |||